Document is current

Any future updates will be listed below

Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects

Crossref DOI link: https://doi.org/10.1007/s00592-023-02152-6

Published Online: 2023-07-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark